PharmaCielo Colombia has received the Good Agricultural and Collection Practices (“GACP”) designation for the production of medicinal cannabis. The certification was awarded to the Company by SGS following a rigorous auditing process that started last year.
The GACP designation awarded to PharmaCielo is based on the guidelines of the World Health Organization related to quality assurance and control of medicinal plants. These guidelines provide technical guidance on obtaining medicinal plant materials of good quality for the sustainable production of herbal products classified as medicines.
“Obtaining the GACP designation, along with the ISO 9001:2015 and the recent recognition of the Company as a Project of National Strategic Interest are important accomplishments that will help us streamline exporting opportunities and open additional international markets for our high-quality medicinal-grade extracts,” said Henning von Koss, President of PharmaCielo Ltd.
The GACP designation is a step above the GAP (Good Agricultural Practices) certification that PharmaCielo already secured earlier this year and brings the Company a step closer to EU Good Manufacturing Practices (“EU-GMP”) compliance, which will open additional opportunities for export of its medicinal-grade cannabis extracts.
The GACP certification was issued by SGS, one of the world’s leading inspection, verification, testing and certification companies. Good Agricultural and Collection Practices are guidelines that have been developed in recent years by the WHO. These guidelines concern the cultivation and collection of medicinal plants and include certain post-harvest operations.